Verve Therapeutics
VERV
$6.66
Share price
-1.19%
Change (1 day)
-57.82%
Change (1 year)
Revenue for Verve Therapeutics (VERV)
Revenue in 2023 (TTM): $11.75 M
According to Verve Therapeutics's latest financial reports the company's current revenue (TTM) is $11.75 M. In 2022 the company made a revenue of $1.94 M an increase over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Verve Therapeutics from 2020 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $11.75 M | 505.77% |
| 2022 | $1.94 M | |
| 2021 | N/A | |
| 2020 | N/A |